650 related articles for article (PubMed ID: 30173560)
1. Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives.
Cong VT; Gaus K; Tilley RD; Gooding JJ
Expert Opin Drug Deliv; 2018 Sep; 15(9):881-892. PubMed ID: 30173560
[TBL] [Abstract][Full Text] [Related]
2. Shape matters when engineering mesoporous silica-based nanomedicines.
Hao N; Li L; Tang F
Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica nanorods for improved oral drug absorption.
Zheng N; Li J; Xu C; Xu L; Li S; Xu L
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1132-1140. PubMed ID: 28783976
[TBL] [Abstract][Full Text] [Related]
4. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
Tang F; Li L; Chen D
Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of mesoporous hollow silica nanospheres using polymeric micelles as template and their application as a drug-delivery carrier.
Sasidharan M; Zenibana H; Nandi M; Bhaumik A; Nakashima K
Dalton Trans; 2013 Oct; 42(37):13381-9. PubMed ID: 23887599
[TBL] [Abstract][Full Text] [Related]
6. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous silica nanoparticles in nanomedicine applications.
Manzano M; Vallet-Regí M
J Mater Sci Mater Med; 2018 May; 29(5):65. PubMed ID: 29737405
[TBL] [Abstract][Full Text] [Related]
8. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
Chen Y; Chen H; Shi J
Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
Giret S; Wong Chi Man M; Carcel C
Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
[TBL] [Abstract][Full Text] [Related]
10. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
Murugan B; Krishnan UM
Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
[TBL] [Abstract][Full Text] [Related]
11. Shape-mediated biological effects of mesoporous silica nanoparticles.
Hao N; Li L; Tang F
J Biomed Nanotechnol; 2014 Oct; 10(10):2508-38. PubMed ID: 25992407
[TBL] [Abstract][Full Text] [Related]
12. Functionalized mesoporous silica particles for application in drug delivery system.
Pang J; Luan Y; Yang X; Jiang Y; Zhao L; Zong Y; Li Z
Mini Rev Med Chem; 2012 Jul; 12(8):775-88. PubMed ID: 22512562
[TBL] [Abstract][Full Text] [Related]
13. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation.
Wang Y; Cui Y; Zhao Y; Zhao Q; He B; Zhang Q; Wang S
J Colloid Interface Sci; 2018 Mar; 513():736-747. PubMed ID: 29220688
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
17. Biotemplated Hollow Mesoporous Silica Particles as Efficient Carriers for Drug Delivery.
Heidari Nia M; Koshani R; Munguia-Lopez JG; Kiasat AR; Kinsella JM; van de Ven TGM
ACS Appl Bio Mater; 2021 May; 4(5):4201-4214. PubMed ID: 35006833
[TBL] [Abstract][Full Text] [Related]
18. Biodegradation-tunable mesoporous silica nanorods for controlled drug delivery.
Park SB; Joo YH; Kim H; Ryu W; Park YI
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():64-73. PubMed ID: 25746247
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
Croissant JG; Fatieiev Y; Almalik A; Khashab NM
Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
[TBL] [Abstract][Full Text] [Related]
20. Silica materials in drug delivery applications.
Simovic S; Ghouchi-Eskandar N; Sinn AM; Losic D; Prestidge CA
Curr Drug Discov Technol; 2011 Sep; 8(3):269-76. PubMed ID: 21291408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
